Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | L-Tartaric acid | HCID 444305 | — |
| Reactant | HCID 25156308 | HCID 25156308 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | HCID 131732589 | HCID 131732589 | 90.9% |
Reaction Steps
To a solution of the aryloxybenzazepine (52 mg, 0.16 mmol) from Step B above in methanol (1 mL) was added L-tartaric acid (23.5 mg, 0.16 mmol) followed by slow addition of water (5 mL). The resultant solution was lyophilized overnight to give (−)-2-methyl-5-phenoxy-8-(pyridazin-3-yl)-2,3,4,5-tetrahydro-1H-benzo[c]azepine, tartrate salt (70 mg, 93%, AUC HPLC>99%) as a white solid: mp 98-100° C.; 1H NMR (CD3OD, 500 MHz) δ 9.17 (d, J=5.0 Hz, 1H), 8.21-8.18 (m, 2H), 8.08 (d, J=8.0 Hz, 1H), 7.82-7.79 (m, 1H), 7.68 (d, J=8.0 Hz, 1H), 7.28-7.25 (m, 2H), 7.06 (d, J=7.9 Hz, 2H), 6.95 (t, J=7.4 Hz, 1H), 5.75 (d, J=8.0 Hz, 1H), 4.92-4.84 (m, 1H), 4.51-4.48 (m, 1H), 4.41 (s, 2H), 3.95-3.85 (m, 1H), 3.57-3.55 (m, 1H), 2.88 (s, 3H), 2.46-2.38 (m, 2H); ESI MS m/z 332 [M+H].
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08987252B2 |
|---|
| Source dataset | uspto-grants-2015_03 |
|---|
| ORD ID | ord-5729b2d5d85f411ab1526e9d6adb13be |
|---|
| Source note | uspto-grants-2015_03 |
|---|